Reproductive biology of the island grouper (Mycteroperca fusca) in the Canary Islands, northwest coast of Africa

[EN]This is the first time that the reproductive characteristics of Mycteroperca fusca have been analyzed over the whole area of its distribution, using the parameter of the histological analysis of the gonads. This species is a protogynous hermaphrodite with a marked predominance of females (1:4.9). The males and females displayed marked differences in the distribution of the sizes. The females were distributed over all the size ranges analyzed (229-725 mm total length), whereas the males were observed within the larger sizes, as of 428 mm. One transitional specimen (610 mm total length) was observed. The size at which the females first reached sexual maturity was 335 mm total length whereas the size at which 95% of females reached sexual maturity was 398 mm total length. The average size at which 50% of the females had inverted to the male condition was found to be 678 mm total length. The range of sizes at which the process of sexual inversion took place was broad, between 428 and 725 mm total length. The reproductive period was long, almost covering the annual cycle, although the maximum activity was observed between April and October, with a peak in spawning in June-July.

Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?

[EN] This study was performed to test the hypothesis that administration of recombinant human erythropoietin (rHuEpo) in humans increases maximal oxygen consumption by augmenting the maximal oxygen carrying capacity of blood. Systemic and leg oxygen delivery and oxygen uptake were studied during exercise in eight subjects before and after 13 wk of rHuEpo treatment and after isovolemic hemodilution to the same hemoglobin concentration observed before the start of rHuEpo administration. At peak exercise, leg oxygen delivery was increased from 1,777.0+/-102.0 ml/min before rHuEpo treatment to 2,079.8+/-120.7 ml/min after treatment. After hemodilution, oxygen delivery was decreased to the pretreatment value (1,710.3+/-138.1 ml/min). Fractional leg arterial oxygen extraction was unaffected at maximal exercise; hence, maximal leg oxygen uptake increased from 1,511.0+/-130.1 ml/min before treatment to 1,793.0+/-148.7 ml/min with rHuEpo and decreased after hemodilution to 1,428.0+/-111.6 ml/min. Pulmonary oxygen uptake at peak exercise increased from 3,950.0+/-160.7 before administration to 4,254.5+/-178.4 ml/min with rHuEpo and decreased to 4,059.0+/-161.1 ml/min with hemodilution (P=0.22, compared with values before rHuEpo treatment). Blood buffer capacity remained unaffected by rHuEpo treatment and hemodilution. The augmented hematocrit did not compromise peak cardiac output. In summary, in healthy humans, rHuEpo increases maximal oxygen consumption due to augmented systemic and muscular peak oxygen delivery.